Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Sandoz Likely To Set Up Base In Chongqing

This article was originally published in PharmAsia News

Executive Summary

Sandoz China's CEO recently visited Chongqing to check out its business environment. City officials gave details of Chongqing's favorable investment climate, highlighting its pharmaceutical industry infrastructure. Some firms already set up there include Chongqing Yaoyou Pharmaceuticals and Chongqing Southwest Synthetic Pharmaceutical. The city is actively attracting top global 500 companies to build up an industrial manufacturing base, thus the collaboration prospects with Sandoz look promising. Sandoz has expressed optimism in Chongqing's development potential and hopes to work with drug enterprises there to boost the expansion of the local pharmaceutical industry for a win-win relationship. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069373

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel